Home > News By Company > RNCOS
Infrastructure Developments to Fuel Indian Clinical Trials Market
The market for clinical trial studies in India is projected to grow at a CAGR of more than 30% in the next three years, says RNCOS in its latest research study.
(EMAILWIRE.COM, January 01, 2010 ) New Delhi, India - The clinical trials market in India has registered a significant growth in last few years. The country promises to be one of the most emerging destinations for conducting global clinical trials because of its huge patient pool representing both chronic and infectious diseases. According to our new research study on the sector called “Booming Clinical Trials Market in India”, the market for clinical trials in India is forecast to grow at a CAGR of around 30% during 2010-2012.
We have found that the high investments in the healthcare facilities by both private and government sectors have boosted the growth in hospitals and diagnostic services in India. Besides this, the number of ICH/GCP compliant sites has also increased exponentially in the country. This has attracted a lot of pharma players to conduct their clinical trials in India. In this regard, the report provides complete details about the current infrastructure developments in the country besides providing statistics of the clinical trials professionals, doctors and hospital beds.
We believe that cost is another major factor attracting the major pharma players in the market and our research gives a complete cost analysis of various phases of clinical trials in India. Moreover, it also includes details of various market drivers and constraints, which will present a clearer picture of the market. Also, the details of regulatory environment have also been added in the report with the aim of making clients aware of the regulatory hurdles.
“Booming Clinical Trials Market in India” provides details on key competitors in the market along with their business information and area of expertise. This will help pharma majors to identify key clinical research organizations in the country where they can conduct clinical trials. Thus, the report serves as a useful guide for pharma and biotech companies, investors and consultants who are planning to enter the India clinical trials market.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM564.htm
Check DISCOUNTED REPORTS on: http://www.rncos.com
About RNCOS:
RNCOS, incorporated in the year 2002, is an industry research firm. We are a team of industry experts who analyze data collected from credible sources. We provide industry insights and analysis that helps corporations to take timely and accurate business decision in today's globally competitive environment.
We have found that the high investments in the healthcare facilities by both private and government sectors have boosted the growth in hospitals and diagnostic services in India. Besides this, the number of ICH/GCP compliant sites has also increased exponentially in the country. This has attracted a lot of pharma players to conduct their clinical trials in India. In this regard, the report provides complete details about the current infrastructure developments in the country besides providing statistics of the clinical trials professionals, doctors and hospital beds.
We believe that cost is another major factor attracting the major pharma players in the market and our research gives a complete cost analysis of various phases of clinical trials in India. Moreover, it also includes details of various market drivers and constraints, which will present a clearer picture of the market. Also, the details of regulatory environment have also been added in the report with the aim of making clients aware of the regulatory hurdles.
“Booming Clinical Trials Market in India” provides details on key competitors in the market along with their business information and area of expertise. This will help pharma majors to identify key clinical research organizations in the country where they can conduct clinical trials. Thus, the report serves as a useful guide for pharma and biotech companies, investors and consultants who are planning to enter the India clinical trials market.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM564.htm
Check DISCOUNTED REPORTS on: http://www.rncos.com
About RNCOS:
RNCOS, incorporated in the year 2002, is an industry research firm. We are a team of industry experts who analyze data collected from credible sources. We provide industry insights and analysis that helps corporations to take timely and accurate business decision in today's globally competitive environment.
Contact Information:
RNCOS
Shushmul Maheshwari
Tel: 91-120-4224-700
Email us
This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.
RNCOS
Shushmul Maheshwari
Tel: 91-120-4224-700
Email us
This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.
|
Private Equity, Angel Investing
Equity Alliance / Private Equity, Angel Investing, / IPO, Venture Capital & IR services / Equity Alliance International Equityallianceir.com Penny Stocks to Watch Sign up for hot penny stock picks Gains of 500%+ possible! Premiumstockpicks.com/landing/ Your text Ads & PR Text Ads plus unlimited press releases, One release featured/Day for only $575 per month. Read more on Text Ads & PR Your text Ads Here! Text Ads are only $289 per month. Ads are placed same day. More on Text Ads Advertising |




